Clinical Trial

Phase II Study of LM-24C5

Name: Phase II Study of LM-24C5 — clinical trial record (NCT07387081)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study is to evaluate the efficacy and safety of the LM-24C5 in combination with other therapies in subjects with CEACAM5-positive advanced solid tumor

Trial Details

NCT Number	NCT07387081
Lead Sponsor	LaNova Medicines Limited
Conditions	Advanced Solid Tumor Cancer
Enrollment	130 participants
Start Date	2025-12-15
Primary Completion	2028-05-21 (estimated)
Study Completion	2028-10-25 (estimated)
Updated on ClinicalTrials.gov	2026-02-04